Evidence map›Paper›PMID 36045674›Full record

ArticleFrontiers in immunology2022

EZH2 restricts

Yuan Luo, Dan Li, Luoyingzi Xie, Shun Lei, Xiangyu Chen, Cong Wang, Dong Yao, Lin Li, Jingyi Fang, Cheng Chen and 10 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 1 country.

Yuan LuoDepartment of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Dan LiDepartment of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Luoyingzi XieInstitute of Immunology, Third Military Medical University, Chongqing, China.
Shun LeiInstitute of Immunology, Third Military Medical University, Chongqing, China.
Xiangyu ChenInstitute of Immunology, Third Military Medical University, Chongqing, China.
Cong WangChongqing General Hospital, University of Chinese Academy of Sciences, Chongqing, China.
Dong YaoDepartment of Anesthesiology, Chongqing Public Health Medical Center, Chongqing, China.
Lin LiDepartment of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jingyi FangInstitute of Immunology, Third Military Medical University, Chongqing, China.
Cheng ChenInstitute of Immunology, Third Military Medical University, Chongqing, China.
Shijie YuanDepartment of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Fei LiDepartment of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xiaorong XieDepartment of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yan ZhangInstitute of Immunology, Third Military Medical University, Chongqing, China.
Zhirong LiInstitute of Immunology, Third Military Medical University, Chongqing, China.
Li HuInstitute of Immunology, Third Military Medical University, Chongqing, China.
Jianfang TangInstitute of Immunology, Third Military Medical University, Chongqing, China.
Lilin YeInstitute of Immunology, Third Military Medical University, Chongqing, China.
Zhengping WeiInstitute of Immunology, Third Military Medical University, Chongqing, China.
Ran HeDepartment of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Army Medical University · CNHuazhong University of Science and Technology · CNChongqing Public Health Medical Center · CNSouthern Medical University · CNUnion Hospital · CNUniversity of Chinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Follicular helper T (T

Indexed as

DNA MethylationT-Lymphocytes, Helper-InducerVirus DiseasesAnimalsCell DifferentiationEnhancer of Zeste Homolog 2 ProteinHepatocyte Nuclear Factor 1-alphaHistone MethyltransferasesMiceEnhancer of Zeste Homolog 2 ProteinEzh2 protein, mouseHepatocyte Nuclear Factor 1-alphaHistone MethyltransferasesHnf1a protein, mouseDNA methylationEZH2LCMVTcf7TFH cells

Identifiers

PMID36045674
PMCPMC9420843
OpenAlexW4291383299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.